Thermo Fisher Scientific (TMO) Non-Current Deferred Tax Liability (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Non-Current Deferred Tax Liability for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $2.1 billion, up 102.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 102.4% YoY), and the FY2025 annual result was $1.5 billion, up 17.74% from the prior year.
• Non-Current Deferred Tax Liability was $2.1 billion for Q1 2026 at Thermo Fisher Scientific, up from $1.5 billion in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $3.5 billion in Q2 2022 and troughed at $624.0 million in Q2 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $2.1 billion, with a median of $1.9 billion recorded in 2023.
• Year-over-year, Non-Current Deferred Tax Liability soared 114.33% in 2022 and tumbled 58.84% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $2.8 billion in 2022, then slumped by 32.54% to $1.9 billion in 2023, then plunged by 34.03% to $1.3 billion in 2024, then climbed by 17.74% to $1.5 billion in 2025, then jumped by 41.13% to $2.1 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $2.1 billion in Q1 2026, $1.5 billion in Q4 2025, and $842.0 million in Q3 2025.